The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Antibiotic Sensitivities[1]
Organisms
|
'
|
Strep, Group A, B, C, G
|
Penicillins |
Penicillin G |
+
|
|
Penicillin V |
+
|
Anti-Staphylocccal Penicillins |
Methicillin |
+
|
|
Nafcillin/Oxacillin |
+
|
|
Cloxacillin/Diclox. |
+
|
Amino-Penicillins |
AMP/Amox |
+
|
|
Amox/Clav |
+
|
|
AMP-Sulb |
+
|
Anti-Pseudomonal Penicillins |
Ticarcillin |
+
|
|
Ticar-Clav |
+
|
|
Pip-Taxo |
+
|
Carbapenems |
Piperacillin |
+
|
|
Doripenem |
+
|
|
Ertapenem |
+
|
|
Imipenem |
+
|
|
Meropenem |
+
|
|
Aztreonam |
0
|
Fluroquinolones |
Ciprofloxacin |
+/-
|
|
Ofloxacin |
+/-
|
|
Pefloxacin |
0
|
|
Levofloxacin |
+
|
|
Moxifloxacin |
+
|
|
Gemifloxacin |
+
|
|
Gatifloxacin |
+
|
1st G Cephalo |
Cefazolin |
+
|
2nd G. Ceph |
Cefotetan |
+
|
|
Cefoxitin |
+
|
|
Cefuroxime |
+
|
3rd/4th G. Ceph |
Cefotaxime |
+
|
|
Cefizoxime |
+
|
|
CefTRIAXone |
+
|
|
Ceftobiprole |
+
|
|
Ceftaroline |
+
|
|
CefTAZidime |
+
|
|
Cefepime |
+
|
1st G. Ceph |
Cefadroxil |
+
|
|
Cephalexin |
+
|
2nd G. Ceph |
Cefaclor/Loracarbef |
+
|
|
Cefproxil |
+
|
|
Cefuroxime axetil |
+
|
3rd G. Ceph |
Cefixime |
+
|
|
Ceftibuten |
+
|
|
Cefpodox/Cefdinir/Cefditoren |
+
|
Aminoglycosides |
Gentamicin |
0
|
|
Tobramycin |
0
|
|
Amikacin |
0
|
|
Chloramphenicol |
+
|
|
Clindamycin |
+
|
Macrolides |
Erythromycin |
+/-
|
|
Azithromycin |
+/-
|
|
Clarithromycin |
+/-
|
Ketolide |
Telithromycin |
+
|
Tetracyclines |
Doxycycline |
+/-
|
|
Minocycline |
+
|
Glycylcycline |
Tigecycline |
+
|
Glyco/Lipoclycopeptides |
Vancomycin |
+
|
|
Teicoplanin |
+
|
|
Telavancin |
+
|
|
Fusidic Acid |
+/-
|
|
Trimethoprim |
+
|
|
TMP-SMX |
+
|
Urinary Agents |
Nitrofurantoin |
+
|
|
Fosfomycin |
|
Other |
Rifampin |
+
|
|
Metronidazole |
0
|
|
Quinupristin dalfoppristin |
+
|
|
Linezolid |
+
|
|
Daptomycin |
+
|
|
Colistimethate |
0
|
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
Table Overview
See Also
- ↑ Sanford Guide to Antimicrobial Therapy 2010